Luspatercept Alternatives Compared
Luspatercept | Reblozyl | Epoetin alfa |
|
---|
Luspatercept | Reblozyl (luspatercept) | Epoetin alfa |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Myelodysplastic Syndrome, Anemia, Beta Thalassemia. luspatercept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myelodysplastic Syndrome, Anemia, Beta Thalassemia. Reblozyl may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia, Anemia - Chemotherapy Induced, Anemia - Drug Induced, Anemia Prior to Surgery. epoetin alfa may also be used for purposes not listed in... View more |
Related suggestions |
|||||||
More about Luspatercept | More about Reblozyl (luspatercept) | More about Epoetin alfa | ||||||||
Ratings & Reviews | ||||||||||
Luspatercept has an average rating of 8.9 out of 10 from a total of 7 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 0% reported a negative effect. |
Reblozyl has an average rating of 9.6 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Epoetin alfa has an average rating of 4.6 out of 10 from a total of 8 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: luspatercept side effects in more detail. |
See also: Reblozyl side effects in more detail. |
See also: epoetin alfa side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Reblozyl prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Reblozyl |
N/A |
Epogen, Procrit, Retacrit | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
264 hours |
264 hours |
19 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 2 drugs are known to interact with luspatercept:
|
A total of 2 drugs are known to interact with Reblozyl:
|
A total of 21 drugs are known to interact with epoetin alfa:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
November 08, 2019 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.